These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 3544222)

  • 1. Splanchnic hemodynamics in chronic portal hypertension.
    Benoit JN; Granger DN
    Semin Liver Dis; 1986 Nov; 6(4):287-98. PubMed ID: 3544222
    [No Abstract]   [Full Text] [Related]  

  • 2. Splanchnic and systemic hemodynamic alterations in chronic, progressive portal hypertensive rats.
    Blanchart A; Garrido MC; Fernández-Muñoz D; Nuño J; Hernando L; López-Novoa JM
    Rev Esp Fisiol; 1984 Dec; 40(4):493-9. PubMed ID: 6397796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nitric oxide and portal hypertension: its role in the regulation of intrahepatic and splanchnic vascular resistance.
    Wiest R; Groszmann RJ
    Semin Liver Dis; 1999; 19(4):411-26. PubMed ID: 10643626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostacyclin production in acute, chronic, and long-term experimental portal hypertension.
    Sitzmann JV; Campbell K; Wu Y; St Clair C
    Surgery; 1994 Mar; 115(3):290-4. PubMed ID: 8128353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hyperdynamic status in a partial portal vein ligated (PVL) rat's portal hypertension model].
    Wang CT; Kuang YL; Chen ZP
    Zhonghua Wai Ke Za Zhi; 1994 Sep; 32(9):573-5. PubMed ID: 7720436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Role of nitric oxide in alterations of the systemic and splanchnic hemodynamics in a experimental model of portal hypertension].
    Albornoz L; Bandi JC; Sánchez S; Spinedi E; Canteros G; De Paula JA; Galdame O; Mastai R
    Medicina (B Aires); 1994; 54(1):17-24. PubMed ID: 7990681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemodynamic changes after ligation of a major branch of the portal vein in rats: comparison with rats with portal vein constriction.
    Um SH; Nishida O; Tokubayashi M; Kimura F; Takimoto Y; Yoshioka H; Inque R; Kita T
    Hepatology; 1994 Jan; 19(1):202-9. PubMed ID: 8276356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of the development of portosystemic shunts in the maintenance of portal hypertension in rats].
    Braillon A; Koshy A; Lee SS; Girod C; Lebrec D
    Gastroenterol Clin Biol; 1988; 12(8-9):641-5. PubMed ID: 3215429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Splanchnic hyposensitivity to glypressin in a haemorrhage/transfused rat model of portal hypertension: role of nitric oxide and bradykinin.
    Chu CJ; Wu SL; Lee FY; Wang SS; Chang FY; Lin HC; Chan CC; Lee SD
    Clin Sci (Lond); 2000 Dec; 99(6):475-82. PubMed ID: 11099389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of propranolol on portal hemodynamics in patients with chronic liver disease.
    Ohnishi K; Nakayama T; Saito M; Hatano H; Tsukamoto T; Terabayashi H; Sugita S; Wada K; Nomura F; Koen H
    Am J Gastroenterol; 1985 Feb; 80(2):132-5. PubMed ID: 3881933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of VEGF receptor-2 decreases the development of hyperdynamic splanchnic circulation and portal-systemic collateral vessels in portal hypertensive rats.
    Fernandez M; Mejias M; Angermayr B; Garcia-Pagan JC; Rodés J; Bosch J
    J Hepatol; 2005 Jul; 43(1):98-103. PubMed ID: 15893841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Splanchnic hemodynamics in idiopathic portal hypertension: comparison with chronic persistent hepatitis.
    Ohnishi K; Sato S; Nomura F; Iida S
    Am J Gastroenterol; 1989 Apr; 84(4):403-8. PubMed ID: 2929561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Physiology of the portal system and physiopathology of portal hypertension].
    Lebrec D
    Rev Prat; 1990 Jun; 40(16):1450-3. PubMed ID: 2193365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased expression of endothelin receptors in the vasculature of portal hypertensive rats: role in splanchnic hemodynamics.
    Cahill PA; Hou MC; Hendrickson R; Wang YN; Zhang S; Redmond EM; Sitzman JV
    Hepatology; 1998 Aug; 28(2):396-403. PubMed ID: 9696003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hemodynamic study of portal hypertension].
    Poo JL
    Rev Gastroenterol Mex; 1994; 59(2 Suppl):65-72. PubMed ID: 8091100
    [No Abstract]   [Full Text] [Related]  

  • 16. Modulation of portosystemic shunting by prostacyclin in portal hypertension.
    Campbell KA; Wu YP; Sitzmann JV
    Curr Surg; 1990; 47(1):17-9. PubMed ID: 2107062
    [No Abstract]   [Full Text] [Related]  

  • 17. Restriction of drinking water abrogates splanchnic vasodilation and portal hypertension in portal vein-ligated rats.
    Heinemann A; Schuligoi R; Lippe IT; Stauber RE
    Pharmacology; 2009; 83(1):26-32. PubMed ID: 18987488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of F-180, a new selective vasoconstrictor peptide, compared with terlipressin and vasopressin on systemic and splanchnic hemodynamics in a rat model of portal hypertension.
    Bernadich C; Bandi JC; Melin P; Bosch J
    Hepatology; 1998 Feb; 27(2):351-6. PubMed ID: 9462630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pathophysiology of portal hypertension: a basis for classification.
    Groszmann RJ; Atterbury CE
    Semin Liver Dis; 1982 Aug; 2(3):177-86. PubMed ID: 7178896
    [No Abstract]   [Full Text] [Related]  

  • 20. Hyperdynamic circulation in a chronic murine schistosomiasis model of portal hypertension.
    Sarin SK; Mosca P; Sabbà C; Groszmann RJ
    Hepatology; 1991 Mar; 13(3):581-4. PubMed ID: 1900255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.